Cannabinoid control of neuroinflammation related to multiple sclerosis.
about
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability.The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiationEvaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.Inflammatory markers among adolescents and young adults with bipolar spectrum disorders.The endocannabinoid system as a target for the treatment of motor dysfunction.The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.Cannabinoids and their actionsLaquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
P2860
Q30670447-99E3CA70-7120-4902-B875-CECE2A44F2EBQ33581824-BC98C2D0-C2B7-41C6-A021-9D3696CE6CDEQ35842324-A5152FE3-D8CB-40C7-BEA0-4DFFE4DE6DCEQ36130163-BF016929-0FC2-448B-BF91-A4C5EDD5DE78Q36178329-2F5AE19A-B8A4-433A-BB16-FDFD3779A550Q36247115-84CF3920-9668-4F33-92AB-7D14D24F9502Q36370835-34117020-0379-4919-A995-0DB96BF132C3Q36977336-D7EBBBFE-ECD8-4170-AC0A-91E20A16A623Q37394164-28D77B0D-C575-4853-A023-57BD686FF9BCQ37988405-D8BE8C83-E6FE-452D-992C-FD1AF02658D0Q39580210-059FA48B-EBE7-42F0-BB3E-FBEF28CF7ABEQ48256822-1B170E20-42F7-47F2-AC38-2A236A467FCC
P2860
Cannabinoid control of neuroinflammation related to multiple sclerosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@ast
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@en
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@nl
type
label
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@ast
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@en
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@nl
prefLabel
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@ast
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@en
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@nl
P2093
P2860
P921
P356
P1476
Cannabinoid control of neuroinflammation related to multiple sclerosis.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707458
P407
P577
2007-09-24T00:00:00Z